| Product NDC: | 66116-360 |
| Proprietary Name: | Glyburide |
| Non Proprietary Name: | Glyburide |
| Active Ingredient(s): | 5 mg/1 & nbsp; Glyburide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 66116-360 |
| Labeler Name: | MedVantx, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074388 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110718 |
| Package NDC: | 66116-360-60 |
| Package Description: | 60 TABLET in 1 BOTTLE (66116-360-60) |
| NDC Code | 66116-360-60 |
| Proprietary Name | Glyburide |
| Package Description | 60 TABLET in 1 BOTTLE (66116-360-60) |
| Product NDC | 66116-360 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Glyburide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110718 |
| Marketing Category Name | ANDA |
| Labeler Name | MedVantx, Inc. |
| Substance Name | GLYBURIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |